Skip to main content
Tessa NewsLink
Paste a health news link, or browse
Latest checks

Source study found

Story checked

Major studies identify accurate non-invasive tests for liver disease (opens in a new tab)

news-medical.net · 2026-10-29

Short answerEvidenceSource

Short answer

Not assessed

Check incomplete.

We found a likely source study, but its evidence could not be prepared for claim review. The article's claims remain unverified.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Source study identified.

A source study was identified, but the study's evidence could not be prepared for claim assessment. No claim verdicts are available.

View article claims
3

The source study

Non-invasive tests in metabolic dysfunction-associated steatotic liver disease: the LITMUS prospective multicentre diagnostic accuracy study

The Lancet · 2026
Open source record (opens in a new tab)
Then inspect each claim

Evidence layer

Claim by claim

A source study was identified, but the study's evidence could not be prepared for claim assessment. The claims below have not been assessed.

Claim 1 of 10Not checkedTwo major international studies have delivered the strongest evidence to date on which non-invasive tests can accurately diagnose and measure the severity of MASLD and MASH, reducing reliance on liver biopsy.View evidenceHide evidence

As statedstrongest evidence to date

Not checked

A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.

Claim 2 of 10Not checkedThe studies are part of the LITMUS programme and were published in The Lancet and Nature Medicine.View evidenceHide evidence

As statedlargest international effort

Not checked

A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.

Claim 3 of 10Not checkedThe main LITMUS Study in The Lancet assessed blood tests and ultrasound-based liver stiffness measurements in more than 1,500 patients, described as the largest international study of its kind.View evidenceHide evidence

As statedmore than 1,500 patients

Not checked

A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.

Claim 4 of 10Not checkedThe companion LITMUS Imaging Study in Nature Medicine examined advanced MRI and elastography techniques in more than 350 patients.View evidenceHide evidence

As statedmore than 350 patients

Not checked

A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.

Claim 5 of 10Not checkedFor advanced liver fibrosis and cirrhosis, the SOMAScan proteomic panel, MR elastography, and FibroScan-based elastography tools, including the Agile 3+ score, delivered the highest diagnostic accuracy.View evidenceHide evidence

As statedhighest levels of diagnostic accuracy

Not checked

A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.

Claim 6 of 10Not checkedThe ELF and ADAPT blood tests also exceeded predefined performance thresholds for detecting cirrhosis.View evidenceHide evidence

As statedexceeded predefined performance thresholds

Not checked

A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.

Claim 7 of 10Not checkedFor identifying 'at-risk MASH', only the SOMAScan panel met the predefined accuracy threshold.View evidenceHide evidence

As statedonly the SOMAScan panel met the predefined accuracy threshold

Not checked

A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.

Claim 8 of 10Not checkedA gamma-GT blood test outperformed the widely used FIB-4 score as a first-line assessment tool and could be followed by FibroScan or ELF testing to confirm disease severity in routine care.View evidenceHide evidence

As statedoutperformed

Not checked

A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.

Claim 9 of 10Not checkedThe findings support a simplified diagnostic pathway using gamma-GT first, then ELF or FibroScan, with advanced imaging reserved for specialist care.View evidenceHide evidence

Not checked

A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.

Claim 10 of 10Not checkedThe LITMUS Imaging Study also found that elastography techniques performed well for detecting advanced fibrosis and cirrhosis, with MR elastography outperforming FibroScan-based liver stiffness measurements.View evidenceHide evidence

As statedoutperforming

Not checked

A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Open the paper in Tessa

Non-invasive tests in metabolic dysfunction-associated steatotic liver disease: the LITMUS prospective multicentre diagnostic accuracy study

The Lancet · 2026

Source record (opens in a new tab)

Why this one

Confident

NewsLink found the paper. Tessa is where you inspect it deeply.

Papers considered

The selected paper, plus nearby candidates.

Crossref, PubMed, Europe PMC · 16 candidate papers

Selected

Non-invasive tests in metabolic dysfunction-associated steatotic liver disease: the LITMUS prospective multicentre diagnostic accuracy study

The Lancet · 2026 · Crossref

Source (opens in a new tab)

And 10 more candidates considered.